Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

Andrew Howden

Andrew Howden

Chairman, ASLAN Pharmaceuticals
  • Senior pharmaceutical executive with more than 35 years of experience in Asia Pacific and Europe
  • Currently, Executive Chairman of First Pharma P/L, an Australian pharmaceutical company
  • Previously, CEO of iNova Pharmaceuticals, a global pharmaceutical company developing and commercialising drugs across a range of therapeutic areas and Chairman of True Origins Company P/L, an Australian company involved in the marketing of infant formula in China and Asia
  • Regional Vice President of Asia Pacific, AstraZeneca; President of Asia Pacific, IMS Health; and senior executive roles at Quintiles
  • Holds a Bachelor of Science Degree and a Masters of Commerce from the University of New South Wales, Australia
  • Member of the Audit Committee
  • Member of the Nomination Committee
  • Chair of the Remuneration Committee

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

contact@aslanpharma.com